Back
Solid Biosciences Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
17
SLDB
Solid Biosciences
Last Price:
5.53
Seasonality Move:
38.41%
Sell
35
SRPT
Sarepta Therapeutics
Last Price:
126.02
Seasonality Move:
11.13%
Sell
17
Solid Biosciences (SLDB)
is a Sell
Is Solid Biosciences a Buy, Sell or Hold?
- The current Solid Biosciences [SLDB] share price is $5.74. The Score for SLDB is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- SLDB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $127.70. The Score for SRPT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLDB Stock Price Chart
What is Solid Biosciences's stock price today?
-
The Solid Biosciences share price today is $5.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLDB is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $127.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
SLDB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 38.72 | Sell |
Chaikin Money Flow: | -106243 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.82 - 6.9) | Sell |
Bollinger Bands (100): | (6.34 - 8.72) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.94 | Buy |
Relative Strength Index (14 RSI): | 51.39 | Buy |
Chaikin Money Flow: | -461949 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.9 - 128.96) | Buy |
Bollinger Bands (100): | (123.22 - 147.2) | Sell |
SLDB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.72 | Buy |
20-day SMA: | 6.22 | Sell |
50-day SMA: | 7.34 | Sell |
200-day SMA: | 8.62 | Sell |
8-day EMA: | 5.83 | Sell |
20-day EMA: | 6.22 | Sell |
50-day EMA: | 6.94 | Sell |
200-day EMA: | 7.6 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.61 | Sell |
20-day SMA: | 125.1 | Buy |
50-day SMA: | 128.55 | Sell |
200-day SMA: | 130.41 | Sell |
8-day EMA: | 128.87 | Sell |
20-day EMA: | 127.21 | Buy |
50-day EMA: | 128.66 | Sell |
200-day EMA: | 127.96 | Sell |
Solid Biosciences Earnings Growth & SLDB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.12 per share, and an increase next year of $0.14 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.
Solid Biosciences Technical Analysis
Oct 17 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |